BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2886590)

  • 1. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in-vivo by phenelzine.
    Green AL; O'Grady JE; Vass M
    J Pharm Pharmacol; 1989 Jan; 41(1):50-1. PubMed ID: 2565965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by tricyclic antidepressant drugs.
    Achee FM; Gabay S
    Biochem Pharmacol; 1979 Apr; 28(7):1197-203. PubMed ID: 444277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tris buffers on rat liver mitochondrial monoamine oxidase.
    Fowler CJ; Callingham BA; Houslay MD
    J Pharm Pharmacol; 1977 Jul; 29(7):411-5. PubMed ID: 19579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B.
    Reid AA; Hill JL; Murphy DL
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):678-83. PubMed ID: 3244400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver monoamine oxidase in the obese-hyperglycaemic (ob/ob) mouse.
    Tong JH; Limson-Zamora M; D'Iorio A; Bégin-Heick N
    Biochem J; 1979 Mar; 177(3):943-9. PubMed ID: 444212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human brain type B monoamine oxidase by tricyclic psychoactive drugs.
    Roth JA
    Mol Pharmacol; 1978 Jan; 14(1):164-71. PubMed ID: 24168
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidation of beta-phenylethylamine by both types of monoamine oxidase: examination of enzymes in brain and liver mitochondria of eight species.
    Suzuki O; Katsumata Y; Oya M
    J Neurochem; 1981 Mar; 36(3):1298-301. PubMed ID: 7205271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.
    Muth EA; Haskins JT; Moyer JA; Husbands GE; Nielsen ST; Sigg EB
    Biochem Pharmacol; 1986 Dec; 35(24):4493-7. PubMed ID: 3790168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.
    White HL; Glassman AT
    J Neurochem; 1977 Dec; 29(6):987-97. PubMed ID: 599351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver monoamine oxidase activity of the lamprey Lampetra fluviatilis. the substrate-inhibitory specificity].
    Iagodina OV; Basova IN
    Zh Evol Biokhim Fiziol; 2013; 49(1):39-43. PubMed ID: 23662480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver].
    Nabatame E
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):374-86. PubMed ID: 5165262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.